Multiple studies have correlated the structure and composition of the gut microbiome with the risk of graft versus host disease after allogeneic hematopoietic cell transplant. Follow-up studies have pointed to possible mechanisms driving this correlation. The promise now is to manipulate the gut microbiome after transplant to improve outcomes.
